Why Partner?
Partner with the Tumour Models Summit Nordics
The field of oncology modelling is transforming rapidly. With the FDA Modernization Act enabling the use of more sophisticated, patient-derived models and a global push toward precision oncology, the demand for advanced tumour models is accelerating. The Nordic region is emerging as a hub for innovation, driven by the need to replicate the complexities of the tumour microenvironment more effectively.
The Tumour Models Summit Nordics is your gateway to this thriving market. Connect with 70+ senior decision-makers from Sweden, Norway, Denmark, and Finland, and position your brand as a leader in cutting-edge oncology solutions. This exclusive event offers unparalleled opportunities to showcase your expertise, forge strategic partnerships, and expand your market presence.
Why Partner with Us?
This summit provides a highly targeted platform to:
Showcase Your Expertise
Build Strategic Partnerships
Expand Your Market Presence
Demonstrate your capabilities in:
- In vivo and in vitro modelling
- Advanced imaging technologies
- Translational biomarker solutions
Lead the conversation on driving precision oncology forward.
Engage directly with senior decision-makers from pharma, biotech, and academia. Meet professionals actively seeking innovative tools and technologies to advance preclinical and translational oncology.
Establish your brand in the Nordic biotech ecosystem - a rapidly growing hub for precision oncology and next-generation tumour modelling.
What Our Attendees Are Looking For:
  Preclinical CROs: Position yourself as a trusted partner in tumour model innovation. Engage with pharma and biotech leaders seeking platforms and technologies to de-risk studies and accelerate clinical success.
  Biomarker Assays: Showcase your expertise in biomarker identification and validation to support precision oncology, enhance therapeutic predictions, and optimize trial outcomes.
  AI Tools & Software: Highlight your AI-powered solutions that streamline tumour model analysis, enable predictive modelling, and bridge the gap between preclinical and clinical research.
  Imaging & Digital Pathology: Promote your advanced imaging and digital pathology tools. Enabling deeper analysis, improve workflows, and boost success rates in drug development.
